Cellectis S.A. ADR (CLLS)
NASDAQ: CLLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CLLS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $134.96M
- EPS (TTM)
- -$0.64
- Dividend yield
- None
- 52-week range
- 1.25 – 5.48
- Day range
- 1.33 – 1.40
- Volume / Avg
- 62.43K / 77.74K
- Beta
- —
- Shares outstanding
- 72.72M
- Next earnings
- Nov 6, 2026
52-week range
CLLS stock today
Cellectis S.A. (CLLS) closed at $1.34 on Oct 7, down 4.29% (-$0.06), versus the S&P 500's 0.22% decline. At this level, CLLS sits near the bottom of its 52-week range of $1.25 to $5.48: 75.5% below the high, set on Oct 16, 2025 and 7.2% above the low. CLLS is down 72.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 64.9%.
Cellectis S.A. has posted a net loss over the last twelve months (EPS of -$0.64), so its P/E ratio is not meaningful. Cellectis S.A.'s next earnings report is expected on Nov 6, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Cellectis S.A.
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2015
Earnings
Earnings history- Next report
- Nov 6, 2026
Cellectis S.A. peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TLSATiziana Life Sciences Ltd. | 1.10 | -0.90% | $139.99M | vs CLLS |
| OGIOrganigram Global Inc. | 0.96 | -1.04% | $138.39M | vs CLLS |
| SDEVStablecoin Development Corporation | 2.78 | -14.46% | $143.87M | vs CLLS |
| RNAAtrium Therapeutics Inc. | 7.93 | -0.75% | $135.65M | vs CLLS |
| TNXPTonix Pharmaceuticals Holding Corp. | 7.55 | -1.88% | $129.49M | vs CLLS |
| SPRBSpruce Biosciences Inc. | 44.40 | +3.77% | $127.61M | vs CLLS |
| KRROKorro Bio Inc. | 10.49 | +7.48% | $154.47M | vs CLLS |
| HURATuHURA Biosciences Inc. | 1.98 | +1.54% | $126.18M | vs CLLS |
Indexes, lists and sector
Cellectis S.A. stock FAQ
What is Cellectis S.A.'s stock price today?
CLLS last traded at $1.34 as of Oct 7, 4:00 PM EDT, down 4.29% on the day. Prices are delayed at least 15 minutes.
When is Cellectis S.A.'s next earnings date?
Cellectis S.A. is expected to report earnings on Friday, November 6, 2026.
What is the CLLS 52-week high?
The 52-week high for CLLS is $5.48 and the 52-week low is $1.25. The stock is currently 75.5% below its high.